NFKB1 and cancer: It has been reported that NF-κB and STAT3 cooperate to promote the development and progression of gastric, colon, and liver cancers, which contribute to explain the molecular pathogenesis of cancers, and offer opportunities for the design of new therapeutic interventions [36].